SIBN
SI-BONE, Inc.
$17.25
+0.34 (+2.01%)
At close · Jul 15
Market Cap
$764.58M
Shares
44,349,283
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$17.25
Open$16.73
Day$16.73–17.37
52W$11.48–21.89
Avg vol 30d573K
Short int6.0M · 13.5% float · 8.5d
Short vol40%
Last earningsMay 11, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 11
Up next
Next earnings call
Aug 14, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 11, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.5 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+9%
above
Price vs 50-day avg
+13%
above
RSI (14)
58
neutral
MACD trend
Negative
52-week position
55%
mid-range
Momentum
relative strength
1-month return
+14%
trailing
6-month return
+2%
trailing
YTD return
−13%
this year
Relative strength
−9%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $15 › 200d $16 — 200d above 50d
Institutional flow
Distributing
6 of 179 funds reported for Jun 30 · net -236.2K sh shares
Insider flow
Distributing
Net -$614.2K over 90 days · 100% sells
Short interest
Rising
13.48% of float · ▲ +0.9% MoM · 8.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
179 holders — near 3-yr high, broad support
Squeeze score
78
high risk · 0–100
Fundamentals
Revenue growth
+22%
Y/Y
Gross margin
238%
contracting
EPS growth
+41%
Y/Y
Free cash flow
$-9.1M
Balance sheet
$6.7M
net cash
Quant / Vol
risk profile
Volatility
51%
annualized · 1-yr
Max drawdown
−46%
past year
ATR
4.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 11, 2026
Worldwide revenue
· Fiscal Year 2026
Initiated
$230M – $233M
prior FY $200.93M
midpoint +15.2% Y/Y
Gross Margin
· Fiscal Year 2026
Initiated
79%
Operating Expenses
· Fiscal Year 2026
Initiated
12.5%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+9%
Bullish
Price vs 50-day avg
+13%
Bullish
RSI (14)
58
Neutral
MACD trend
Negative
Bearish
52-week position
55%
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $15 › 200d $16 — 200d above 50d
Institutional flow
Distributing
6 of 179 funds reported for Jun 30 · net -236.2K sh shares
Insider flow
Distributing
Net -$614.2K over 90 days · 100% sells
Short interest
Rising
13.48% of float · ▲ +0.9% MoM · 8.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
179 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $11
Now $17 · 55%
52-wk high $22
vs 200-day avg +9%
vs 50-day avg +13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Active U.S. physicians | 1,650 | First Quarter 2026 | — |
| Adjusted EBITDA non-GAAP | $2.5M | First Quarter 2026 | — |
| Trailing 12-month average revenue per territory | $2.2M | First Quarter 2026 | — |
| U.S. physicians performed a procedure in the fourth quarter | 1,640 | the fourth quarter | — |
| Active physicians in the U.S. | 1,640 | Q4 FY2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SIBN
this stock
SI-BONE, Inc.
|
$764.58M | -12.5% | +21.5% | — | 13.5% |
|
ABT
Abbott Laboratories
|
$154.67B | -28.4% | +5.7% | 24.9 | 1.3% |
|
SYK
Stryker Corp
|
$120.24B | -9.7% | +11.2% | 36.3 | 1.8% |
|
MDT
Medtronic plc
|
$102.89B | -15.5% | +8.4% | 21.6 | 1.5% |
|
BSX
Boston Scientific Corp
|
$64.07B | -54.9% | +5.5% | 18.0 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SIBN | +2.1% | +14.1% | +1.6% | +5.7% | -12.5% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | +0.9% | +14.3% | -8.5% | +4.6% | -23.2% |